Related by context. Frequent words. (Click for all words.) 60 orally bioavailable 60 Mipomersen 59 SCH # 57 selective inhibitor 57 CCX# 56 Traficet EN 55 OncoVEX GM CSF 55 GLPG# 55 immunomodulator 55 humanized monoclonal antibody 54 PARP inhibitor 54 DB# [003] 54 integrase inhibitor 54 BMS # 54 NNRTIs 54 Voreloxin 54 Sym# 53 MEK inhibitor 53 StemEx 53 FLT3 52 Bortezomib 52 HGS ETR1 52 anticancer compound 52 thymalfasin 52 BAY #-# 52 intravenously administered 52 Bavituximab 52 double blinded placebo 52 CXA 52 phase IIb clinical 52 CD# antibody [001] 51 Cethromycin 51 pertuzumab 51 HCV protease inhibitor 51 celgosivir 51 Azedra 51 Phase 2a trial 51 multiple ascending dose 51 transcriptase inhibitor NNRTI 51 elotuzumab 51 radiolabeled 51 administered subcutaneously 50 hepatitis C HCV 50 EZN 50 MORAb 50 Phase 1b clinical 50 xenograft models 50 BrachySil 50 Nexavar ® 50 CRx 50 VQD 50 Phase 2a clinical 50 Phase Ib clinical 50 rNAPc2 50 Phase 1a 50 Amrubicin 50 potent inhibitor 49 azoles 49 RGB # 49 deforolimus 49 Phase 2b study 49 TG# [001] 49 nucleoside analogue 49 KNS # 49 Cloretazine R VNP#M 49 DAVANAT 49 INGN 49 registrational trial 49 phase IIa 49 transcriptase inhibitor 49 LY# [002] 49 NRTI 49 Phase 1b trial 49 metastatic renal cell carcinoma 49 preclinical toxicology 48 nelfinavir 48 phase 2a 48 Staccato loxapine 48 Zolinza 48 Diamyd ® 48 Lu AA# 48 active comparator 48 single ascending dose 48 Phase IIa trial 48 ascending doses 48 Onalta 48 Perifosine 48 IND enabling 48 daunorubicin 48 Hepatitis C virus HCV 47 tanespimycin 47 Phase IIa clinical 47 PF # [001] 47 Phase 1b 47 AEZS 47 confirmatory Phase III 47 phase IIb 46 ARRY 46 vivo efficacy 46 Pegasys ® 46 romidepsin